Page 25 - Research Models News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Fortune Financial Advisors LLC bought a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the 2nd quarter, HoldingsChannel reports. The fund bought 4,146 shares of the medical research company’s stock, valued at approximately $872,000. A number of other institutional investors and hedge funds also recently made changes to […]

Legacy Wealth Asset Management LLC grew its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 6.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,358 shares of the medical research company’s stock after […]

Gulf International Bank UK Ltd cut its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 23.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,136 shares of the medical research company’s stock after selling 1,532 shares during the quarter. […]

Choate Investment Advisors cut its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 34.7% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 2,711 shares during the quarter. Choate […]

Lindbrook Capital LLC lifted its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 97.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 132 shares of the medical research company’s stock after buying an additional 65 shares during the […]